New Fortress Energy
NFE
YETI Holdings
YETI
eBay
EBAY
Teradata Corp
TDC
Workday
WDAY
US Stock MarketDetailed Quotes
GLSI Greenwich LifeSciences
- 12.210
- +0.210+1.75%
Close Mar 17 16:00 ET
- 12.210
- 0.0000.00%
Post 20:01 ET
160.50MMarket Cap-15.07P/E (TTM)
13.330High12.130Low56.27KVolume12.500Open12.000Pre Close717.22KTurnover0.95%Turnover RatioLossP/E (Static)13.14MShares21.44052wk High32.22P/B72.12MFloat Cap10.52052wk Low--Dividend TTM5.91MShs Float158.070Historical High--Div YieldTTM10.00%Amplitude3.262Historical Low12.746Avg Price1Lot Size
About Greenwich LifeSciences Company
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Company Profile
SymbolGLSI
Company NameGreenwich LifeSciences
Listing DateSep 25, 2020
Issue Price5.75
Founded2006
CEOMr. Snehal S. Patel
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address3992 Bluebonnet Drive,Building 14
CityStafford
ProvinceTexas
CountryUnited States of America
Zip Code77477
Phone1-832-819-3232
Company Executives
- Name
- Position
- Salary
- Snehal S. Patel
- Principal Accounting Officer, Chief Executive Officer, Chief Financial Officer and Director
- 2.75M
- Dr. F Joseph. Daugherty
- Chief Medical Officer and Director
- --
- Dr. Jaye Thompson, M.S.,PhD
- Vice President, Clinical and Regulatory Affairs
- --
- David B. McWilliams
- Chairman of the Board
- 98.39K
- Kenneth Hallock
- Independent Director
- 65.64K
- Eric Rothe
- Independent Director
- 65.64K